Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Rat hepatocyte culture model of macrosteatosis: effect of macrosteatosis induction and reversal on viability and liver-specific function.

Nativ NI, Yarmush G, Chen A, Dong D, Henry SD, Guarrera JV, Klein KM, Maguire T, Schloss R, Berthiaume F, Yarmush ML.

J Hepatol. 2013 Dec;59(6):1307-14. doi: 10.1016/j.jhep.2013.07.019. Epub 2013 Jul 19.

2.

Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol.

Nativ NI, Yarmush G, So A, Barminko J, Maguire TJ, Schloss R, Berthiaume F, Yarmush ML.

Liver Transpl. 2014 Aug;20(8):1000-11. doi: 10.1002/lt.23905. Epub 2014 Jul 2.

3.

Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury.

Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML.

J Surg Res. 2009 Mar;152(1):54-60. doi: 10.1016/j.jss.2007.12.784. Epub 2008 Jan 28.

4.

Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.

El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA.

Hepatology. 2007 Apr;45(4):855-63.

PMID:
17393510
5.

An approach to the rational use of steatotic donor livers in liver transplantation.

Urena MA, Moreno Gonzalez E, Romero CJ, Ruiz-Delgado FC, Moreno Sanz C.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1164-73. Review.

PMID:
10370686
6.

A rapid and reliable means of assessing hepatic steatosis in vivo via electrical bioimpedance.

Hessheimer AJ, Parramón D, Guimerà A, Erill I, Rimola A, García-Valdecasas JC, Villa R, Fondevila C.

Transplantation. 2009 Sep 15;88(5):716-22. doi: 10.1097/TP.0b013e3181b391c0.

PMID:
19741471
7.

Altered alkaline phosphatase activity in obese Zucker rats liver respect to lean Zucker and Wistar rats discussed in terms of all putative roles ascribed to the enzyme.

Bertone V, Tarantola E, Ferrigno A, Gringeri E, Barni S, Vairetti M, Freitas I.

Eur J Histochem. 2011 Feb 8;55(1):e5. doi: 10.4081/ejh.2011.e5.

8.

Optimization of rat hepatocyte culture in citrated human plasma.

Washizu J, Berthiaume F, Chan C, Tompkins RG, Toner M, Yarmush ML.

J Surg Res. 2000 Oct;93(2):237-46.

PMID:
11027466
9.

Hepatocyte transplantation from steatotic liver in a rat model.

Hayashi K, Aoki T, Jin Z, Wang H, Nishino N, Kusano T, Yasuda D, Koizumi T, Enami Y, Odaira M, Yamada K, Mitamura K, Niiya T, Murai N, Kato H, Shimizu Y, Kusano M.

J Surg Res. 2007 Sep;142(1):104-12. Epub 2007 Jun 29.

PMID:
17604052
10.

Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.

Donato MT, Jiménez N, Serralta A, Mir J, Castell JV, Gómez-Lechón MJ.

Toxicol In Vitro. 2007 Mar;21(2):271-6. Epub 2006 Jul 28.

PMID:
16950596
11.

Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.

Donato MT, Lahoz A, Jiménez N, Pérez G, Serralta A, Mir J, Castell JV, Gómez-Lechón MJ.

Drug Metab Dispos. 2006 Sep;34(9):1556-62. Epub 2006 Jun 8.

12.

Evaluation of drug-metabolizing and functional competence of human hepatocytes incubated under hypothermia in different media for clinical infusion.

Gómez-Lechón MJ, Lahoz A, Jiménez N, Bonora A, Castell JV, Donato MT.

Cell Transplant. 2008;17(8):887-97.

PMID:
19069632
13.

Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy.

Ahn JS, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Transplantation. 2013 Jun 15;95(11):1404-9. doi: 10.1097/TP.0b013e31828d1588.

PMID:
23542472
14.

Steatosis does not impair liver regeneration after partial hepatectomy.

Sydor S, Gu Y, Schlattjan M, Bechmann LP, Rauen U, Best J, Paul A, Baba HA, Sowa JP, Gerken G, Canbay A.

Lab Invest. 2013 Jan;93(1):20-30. doi: 10.1038/labinvest.2012.142. Epub 2012 Oct 15.

15.

Sustained spatial disturbance of bile canalicular networks during regeneration of the steatotic rat liver.

Ninomiya M, Shimada M, Terashi T, Ijichi H, Yonemura Y, Harada N, Soejima Y, Suehiro T, Maehara Y.

Transplantation. 2004 Feb 15;77(3):373-9.

PMID:
14966410
16.

Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.

Nagrath D, Xu H, Tanimura Y, Zuo R, Berthiaume F, Avila M, Yarmush R, Yarmush ML.

Metab Eng. 2009 Jul-Sep;11(4-5):274-83. doi: 10.1016/j.ymben.2009.05.005. Epub 2009 Jun 7.

18.

Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?

Hałoń A, Patrzałek D, Rabczyński J.

Transplant Proc. 2006 Jan-Feb;38(1):193-5.

PMID:
16504700
19.

Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.

Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA.

J Hepatol. 2006 Apr;44(4):694-701. Epub 2005 Sep 2.

PMID:
16229921
20.

Inhibitory effect of a new alpha-glucosidase inhibitor on fatty liver in Zucker fatty rats.

Inui Y, Kawata S, Matsuzawa Y, Tokunaga K, Fujioka S, Tamura S, Kobatake T, Keno Y, Odaka H, Matsuo T, et al.

J Hepatol. 1990 Jan;10(1):62-8.

PMID:
2407772

Supplemental Content

Support Center